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Abstract The agr quorum-sensing system is responsible for the
regulation of several virulence factors in staphylococci, with an
extracellular pheromone peptide as signalling molecule. By
monitoring the biological activity of synthetic peptides, it could
be demonstrated that the pheromone of the agr system in
Staphylococcus epidermidis is an octapeptide containing a
thiolester linkage between the central cysteine and the C-
terminal carboxyl group. The peptide was active at nanomolar
concentrations. The N-terminus of the peptide pheromone, which
is encoded as part of a protein precursor, proved to be crucial for
biological activity.
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1. Introduction
The accessory gene regulator (agr) of Staphylococcus aureus
controls the expression of several virulence factors, including
K-toxin, L-toxin, N-toxin, serine protease, DNase, ¢brinolysin,
enterotoxin B and toxic shock syndrome toxin-1. Through the
activities of the agr system, the production of these exopro-
teins is increased in post-exponential growth phase, whereas
the expression of cell wall-associated proteins such as protein
A, coagulase, and ¢bronectin-binding protein is decreased [1^
4].
Among the coagulase-negative staphylococci, S. epidermidis
is considered the prime nosocomial pathogen. The nature of
the regulation of virulence factors in S. epidermidis, including
proteases, N-toxin, lipase and exopolysaccharide (‘slime’), is
unknown. However, an agr-like system would be a likely can-
didate for such regulation, and has been proposed, for exam-
ple, in the case of slime production [5].
The agr locus of S. aureus, about 3.5 kbp in size, comprises
the agrA, agrC, agrD and agrB genes, which are cotranscribed
(RNAII), and the gene for a regulatory RNA molecule,
RNAIII, which also encodes the gene for the N-toxin (hld).
RNAIII controls the expression of target genes in an un-
known fashion. Transcription of RNAII is controlled by the
P2 promoter, and transcription of RNAIII by the P3 pro-
moter [6^8].
The gene products of the agrA and agrC genes form a
classical two-component regulatory system. AgrC is a mem-
brane-associated signal-dependent histidine kinase, which,
upon binding of an extracellular signal, is autophosphorylated
at a histidine residue [7]. As a next step, the response regulator
protein, AgrA, is phosphorylated and activates the transcrip-
tion of RNAII and RNAIII in an unknown manner. It has
been shown that this activation is dependent on the presence
of an additional regulatory protein, SarA [9,10]. The roles of
AgrB and AgrD have recently become more clear. A small
peptide is excised from the AgrD protein, modi¢ed, and se-
creted into the surrounding medium. This peptide represents
the autoinductive signal of the agr system [11,12] and has been
regarded as a pheromone because it signals the state of cell
density to all members of the bacterial population and, ac-
cordingly, represents a means of cell-cell communication [13].
AgrB seems to be involved in the maturation and secretion
process of the modi¢ed peptide. The sequences of the phero-
mone peptides vary among di¡erent groups of S. aureus
strains, and the pheromone peptide of one group can inhibit
the expression of the agr system of another group, while stim-
ulating expression in cells of its own group [12].
Here we report the sequence of the agr system in S. epider-
midis, which appears to be very similar to the analogous se-
quences in S. aureus and S. lugdunensis. The region within
AgrD that encodes the peptide pheromone was sequenced in
15 S. epidermidis strains; only a single type of peptide pher-
omone sequence was found. The biological activity of syn-
thetic peptides was determined by assaying the expression of
a reporter gene that was under the control of the S. epidermi-
dis agr P3 promoter. Our results provide evidence that the
synthetic octapeptide DSVCASYF, which was modi¢ed by
the introduction of a thiolester bond between the cysteine
thiol and the C-terminal carboxyl group, is identical to the
naturally occurring inducing agent.
2. Materials and methods
2.1. Bacterial strains
S. epidermidis ATCC 14990, S. epidermidis Tuº3298 (DSM 3095
[14]), S. epidermidis O-47 [15], S. epidermidis RP62A [16], and 12 S.
epidermidis strains of hospital origin (kindly provided by Prof. G.
Pulverer, Universitaºt Koºln) were used for sequence determination of
the entire, or parts of, the agr coding region.
S. epidermidis Tuº3298 (DSM 3095) was the host for the promoter
test plasmid pRB594P3.
2.2. Plasmids
The promoter test plasmid pRB594 is a derivative of pRB373 [17].
It contains the promoterless pUB112 cat gene [18] adjacent to a multi-
ple cloning site and carries the erythromycin resistance gene ermB
from transposon Tn551. The plasmid pRB594P3 was constructed by
insertion of a BamHI-digested PCR product with the agr P3 region
(and the P2 region in the opposite orientation) of S. epidermidis
ATCC 14990 into the BamHI site of the MCS. BamHI sites were
introduced via the PCR primers at both ends of the PCR product.
The ¢delity and orientation of the inserted PCR product were deter-
mined by DNA sequencing.
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2.3. General methods
Escherichia coli and staphylococcal plasmid DNA was prepared
using Nucleobond AX-100 columns (Macherey-Nagel, Duºren, Ger-
many). For staphylococci, cells were ¢rst treated with 25 Wg/ml lyso-
staphin (Sigma, St. Louis, MO). Transformation of S. epidermidis was
performed by electroporation as described [19]. E. coli-speci¢c re-
combinant DNA techniques were performed according to standard
procedures [20]. Computer analyses of DNA and polypeptide sequen-
ces were performed using MacDNASIS Pro (Hitachi Software Engi-
neering, San Bruno, CA). Enzymes for molecular cloning were ob-
tained from Boehringer-Mannheim or New England Biolabs. S.
epidermidis cells were grown in BM (1% tryptone (Difco), 0.5% yeast
extract (Gibco BRL), 0.5% NaCl, 0.1% K2HPO4, 0.1% glucose).
Staphylococcal cells were disrupted in 20 mM Tris-HCl (pH 7.8) by
glass beads as described [21]. Cell debris was removed by centrifuga-
tion (10 min, 5000Ug). PCR was performed using Vent DNA polym-
erase (New England Biolabs). PCR primers were purchased from
Interactiva (Ulm, Germany). Chromosomal staphylococcal DNA
was prepared according to the method of Mamur [22].
2.4. DNA sequence analysis
DNA was sequenced by cycle sequencing on a DNA sequencer 4000
L (LI-COR Inc., Lincoln, NE) using the Thermo Sequenase £uores-
cent-labelled prime cycle sequencing kit (Amersham, Little Chalfont,
UK). All £uorescent-labelled primers were purchased from MWG-
Biotech (Ebersberg, Germany). The ¢rst oligonucleotide that was
used for sequence determination by primer walking was 5P-GGCAG-
CAGATATCATTTCAACAATCGG-3P.
2.5. Electrospray mass spectrometry
ESI-MS was performed on an API III TAGA Triple Quadrupole
(Perkin Elmer Sciex, Thornhill, Ont., Canada). Samples were dis-
solved in acetonitrile/water (1:1) and introduced into the ion source
at a constant £ow rate of 70 Wl/min. The ori¢ce voltage was set at 80
V.
2.6. Preparative and analytical HPLC
Puri¢cation of crude peptides was performed on a Waters 600
Multi Solvent Delivery System equipped with a Lambda Max Model
481 as detector. A semipreparative column (Nucleosil C18, 4U250
mm; 5 Wm; Grom, Herrenberg, Germany) was used at a £ow rate
of 3.5 ml/min and a linear gradient (10^100% B in 45 min; solvent A:
0.1% TFA (tri£uoroacetic acid) in water; solvent B: 0.1% TFA in
acetonitrile) with V= 214 nm as detection wavelength.
The concentration of puri¢ed peptides, which were redissolved in
DMSO (dimethylsulphoxide), was determined using analytical HPLC
on a Kontron HPLC system with Kroma System 2000 software. An
analytical column (Spherisorb ODS2 2U100 mm; 5 Wm; Grom, Her-
renberg, Germany) was used at a £ow rate of 250 Wl/min and a linear
gradient (0^100% B in 30 min; solvent A: 0.1% TFA in water; solvent
B: 0.1% TFA in acetonitrile) with V= 214 nm as detection wavelength.
A weighed sample of the (unmodi¢ed) peptide DSVCASYF was used
as a reference.
2.7. Synthesis of peptides
The linear and cyclic peptides (SVCASYF/DSVCASYF/GDSVCA-
SYF) were synthesised manually using the £uorenylmethoxycarbonyl
(Fmoc) protocol for solid phase synthesis. All amino acids were from
Novabiochem (Laºufel¢ngen, Switzerland). A Trityl-resin (PepChem;
Clausen and Goldammer, Tuºbingen, Germany) was loaded with
Fmoc-phenylalanine residue used as solid support. Resin substitution
was 0.7 mmol/g and 0.1 mmol amino acid was used for each coupling.
The tert-butyl group was used to protect serine and tyrosine residues.
For linear peptides, a trityl group and for cyclised peptides a meth-
oxytrityl group (Mmt) was used to protect cysteine residues. The
amino acids were coupled using 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetra-
methyluronium tetra£uoroborate and hydroxybenzotriazole (TBTU/
HOBt). Deprotection of the Fmoc-amino acid attached to the resin
was accomplished by using piperidine. For the N-terminal amino
acids, Boc (tert-butyloxycarbonyl) protection was used. Linear pep-
tides were directly cleaved with TFA:TIS (triisopropylsilane) (95:5).
The synthesis route for cyclic peptides comprised cleavage of the
peptides from the resin and removal of the Mmt group performed
in a one-step procedure using DCM (dichloromethane):TFA:TIS
(94:1:5) for 15 min. The ¢ltrates were evaporated, dissolved in
DCM and cyclised with DCC (dicyclohexylcarbodiimide)/DMAP
(4-dimethylaminopyridine) (3 eq.) for 12 h [23]. The solvents were
then evaporated and the other protecting groups were ¢nally cleaved
with TFA:water (90:10) for 2 h. The TFA was removed and the
peptides were dissolved in acetonitrile:water (1:1). The solutions
were ¢ltered and puri¢ed by preparative HPLC. The HPLC fractions
were collected and lyophilised. Purity of peptides was con¢rmed by
HPLC and ESI-MS.
2.8. Chloramphenicol acetyltransferase (CAT) assay
CAT activity was determined according to the method of Shaw [24].
The assay mixture contained 100 mM Tris-HCl (pH 7.8), 0.1 mM
acetyl-Coenzyme A, and 0.4 mg/ml 5,5P-dithiobis-2-nitrobenzoic acid
(DTNB). Assays were performed in 96-well microtitre plates using a
SpectraMax 340 microtitre plate reader (Molecular Devices, Sunny-
vale, CA) with SpectraMaxPro software. 5 Wl cell extract and 5 Wl
5 mM chloramphenicol in 100% ethanol (or 5 Wl 100% ethanol in
controls) were added to 90 Wl of the assay mixture. Cell extracts
were diluted 1:10 or 1:100 with 20 mM Tris-HCl (pH 7.8) when
necessary. Absorption at 412 nm was measured every 15 s for 20
min. The linear part of the resulting curve was used to determine
the CAT activity (absorption coe⁄cient O= 13 600 M31 for DTNB).
For calculation of the speci¢c activity, protein contents of the cell
extracts were determined using the Bio-Rad DC protein assay for
detergent-containing samples (Bio-Rad Laboratories GmbH, Munich,
Germany).
2.9. Sequence data
Sequence data have been submitted to the GenBank database under
accession number AF012132.
3. Results
3.1. The peptide pheromone of the S. epidermidis agr system
The presence of the agr system in the nosocomial pathogen
S. epidermidis was shown by sequencing the entire agr coding
region in strains ATCC 14990 and Tuº3298 (see below). The
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Fig. 1. Comparison of the AgrD proteins of S. aureus, S. lugdunensis, and S. epidermidis. The AgrD protein comprises the sequence of the pep-
tide pheromone, which is cleaved from AgrD and posttranslationally modi¢ed by AgrB [11,12]. The sequences of the peptides puri¢ed from S.
aureus subgroups and from S. lugdunensis [11,12] are underlined. Identical amino acid boxes within the AgrD sequence in the N-terminal and
C-terminal vicinity of the peptide pheromone sequence are shown. The important Cys residue is in bold letters. The sequence directly C-termi-
nal to the pheromone sequence is more conserved than the N-terminal sequence. The lengths of the pheromone peptide sequences of S. aureus
and S. lugdunensis are within 7^9 amino acids [12]. In this study we demonstrate that the modi¢ed octapeptide DSVCASYF (the sequence is
identical in 15 di¡erent S. epidermidis strains) is the biologically active component, whereas the modi¢ed nonapeptide GDSVCASYF and the
modi¢ed heptapeptide SVCASYF show almost no activity.
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coding region of only the peptide pheromone was sequenced
in 15 S. epidermidis strains (strains ATCC 14990, Tuº3298, O-
47 and 12 strains of hospital origin). The corresponding ami-
no acid sequence was the same in all strains sequenced.
The pheromone peptide of the agr system has been de-
scribed in S. aureus. The mass di¡erence of 318 between
the synthetic, unmodi¢ed and the puri¢ed pheromone peptide
of S. aureus implied that the modi¢cation necessary for bio-
logical activity could be a dehydration reaction. Cleavage
analyses suggested the presence of a thiolester bond. It has
been proposed that this thiolester bond is formed between the
central cysteine thiol and the C-terminal carboxyl group
[11,12]. In order to prove that the active peptide in vivo con-
tains the hypothetical thiolactone structure, the stimulatory
biological activity of a pure synthesised thiolactone-containing
peptide needed to be demonstrated.
The pheromones found in S. aureus and S. lugdunensis are
hepta-, octa- or nonapeptides, which di¡er in the length of the
N-terminus, whereas the distance from the central cysteine to
the C-terminus is conserved (Fig. 1). In order to elucidate the
type of modi¢cation in the pheromone as well as to analyse
the in£uence of the N-terminal structure of the S. epidermidis
peptide pheromone on biological activity, we synthesised three
peptides with lengths of 7, 8 or 9 amino acids, each di¡ering
in the length of the N-terminus (SVCASYF, DSVCASYF,
GDSVCASYF). The primary sequence was based on the
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Fig. 3. CAT expression in S. epidermidis Tuº3298 (pRB594P3) upon addition of various synthesised peptides. Flasks containing 100 ml BM
were inoculated with 1/100 vol. of an S. epidermidis Tuº3298 (pRB594P3) preculture and grown with aeration for 10 h. The plasmid pRB594P3
harbours the cat reporter gene under the control of the agr P3 promoter. Optical densities of the cultures were determined hourly. Growth
curves of all cultures were comparable. After 3 h of growth, the peptides SVCASYF, DSVCASYF, GDSVCASYF, as well as their thiolactone-
containing modi¢ed counterparts (‘mod.’), were added to a ¢nal concentration of 20 nM. From this time on, cell extracts were prepared from
samples taken every hour. Speci¢c CAT activities were calculated from CAT activities and protein content determined in triplicate in every cell
extract. Black bars show the CAT activities in the control to which no peptide was added, where CAT activity is a¡ected only by the host-en-
coded agr system.
Fig. 2. P2/P3 promoter region of S. epidermidis ATCC 14990 cloned into pRB594. The ¢gure shows the BamHI fragment obtained by PCR
ampli¢cation comprising the P2/P3 promoter region of S. epidermidis ATCC 14990 which was cloned into the promoter test plasmid pRB594.
Nucleotides shown in bold letters are identical to the S. aureus sequence [3]. The 335 and 310 regions of the P3 promoter, and the transcrip-
tion start site of RNAIII were deduced from the homology to the S. aureus sequence. The Shine-Dalgarno (SD) sequence and the translation
start with the N-terminal sequence of the CAT reporter enzyme are marked.
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DNA sequence encoding the peptide pheromone of S. epider-
midis. In addition to the linear unmodi¢ed peptides, cyclic
peptides with a thiolester bond between the cysteine thiol
and the C-terminal carboxyl group were synthesised. The pep-
tides were shown by ESI-MS and analytical HPLC to be
100% pure. The peptides were diluted in DMSO and the con-
centrations were determined by analytical HPLC (absorption
at 214 nm) relative to a weighed standard of the unmodi¢ed
peptide DSVCASYF.
In order to assay the biological activity of the synthetic
peptides, we developed an assay that uses CAT as a reporter
enzyme. The cat gene was cloned under the control of the S.
epidermidis agr P3 promoter region (Fig. 2). The resulting
promoter test plasmid pRB594P3 harbours an erythromycin
resistance gene. It was transformed in the erythromycin-sensi-
tive S. epidermidis Tuº3298.
By measurement of CAT activity at di¡erent times during
the growth of S. epidermidis Tuº3298 (pRB594P3), we could
demonstrate that the activity of the agr system in S. epidermi-
dis Tuº3298 is growth phase-dependent. At the end of expo-
nential growth phase the CAT activity increased rapidly to a
level that was maintained during stationary phase (Fig. 3,
black bars).
When added to the test strain cultures of S. epidermidis
Tuº3298 (pRB594P3), the correct synthetic pheromone should
increase CAT expression by its action on the host-encoded
AgrA/AgrC two-component regulatory system, which regu-
lates transcription from the P3 promoter. Because the host-
encoded agr peptide pheromone was assumed to superimpose
the exogenous activity during stationary phase, the synthetic
peptides were added 3 h after inoculation when the back-
ground CAT activity was still low. All synthesised modi¢ed
and unmodi¢ed peptides were applied at a concentration of 20
nM in this experiment (Fig. 3). None of the unmodi¢ed pep-
tides, the modi¢ed hepta- or the modi¢ed nonapeptide in-
creased CAT activity when compared to the control. A sig-
ni¢cant increase of CAT activity (twofold after 1 h of growth)
was only found when the thiolactone-containing octapeptide
DSVCASYF was added. This strongly suggests that this pep-
tide is identical to the naturally occurring inducing agent, i.e.
the natural agr peptide pheromone in S. epidermidis.
The relative inducing e¡ect of the modi¢ed DSVCASYF
peptide was highest at 1 h and 2 h after addition, and de-
creased afterwards, probably due to the onset of host-encoded
pheromone expression. In the sample containing the modi¢ed
DSVCASYF peptide, CAT activity was still somewhat higher
in stationary phase compared to the controls (approximately
20%), which implies that the activity of the peptide added
early in growth phase is still present after several hours.
The concentration-dependent e¡ect of the modi¢ed octa-
peptide DSVCASYF on CAT expression was determined us-
ing concentrations between 5 and 500 nM (Fig. 4). CAT ac-
tivities were determined 2 h after addition of the peptide. A
concentration of 10 nM was su⁄cient to result in a detectable
increase in CAT activity, whereas concentrations higher than
100 nM could only slightly further increase the e¡ect.
At a concentration of 200 nM, which is 10 times the con-
centration used in the experiment illustrated in Fig. 3, the
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Table 1
Inducing activities of the modi¢ed (thiolactone-containing) and un-
modi¢ed peptides at a concentration of 200 nM
Peptide (200 nM) Speci¢c CAT activity (U/mg protein)
Without peptide 12.5
GDSVCASYF 11.2
GDSVCASYF modi¢ed 15.6
DSVCASYF 9.8
DSVCASYF modi¢ed 53.3
SVCASYF 8.9
SVCASYF modi¢ed 16.1
Fig. 4. CAT activity in cultures of S. epidermidis (pRB594P3) upon addition of di¡erent concentrations of the thiolactone-containing peptide
DSVCASYF. Flasks containing 50 ml BM were inoculated with precultures of S. epidermidis (pRB594P3), which contained the cat reporter
gene under control of the agr P3 promoter, and were grown with aeration for 3 h. The thiolactone-containing peptide DSVCASYF was then
added to di¡erent ¢nal concentrations of 5, 10, 20, 50, 100, 200, and 500 nM. No peptide was added to the control. After an additional 2 h of
growth, cells were harvested, disrupted and the CAT activities as well as the protein content of the cell extracts were determined in triplicate.
Speci¢c CAT activities were calculated from the values obtained.
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unmodi¢ed peptides still did not show any e¡ect, whereas the
two modi¢ed peptides (thiolactone-containing GDSVCASYF
and SVCASYF) seemed to cause a small stimulatory e¡ect
(Table 1). However, compared to the activity of the thiolac-
tone-containing DSVCASYF, this e¡ect was almost negli-
gible.
3.2. Sequence analysis of the S. epidermidis agr system
The sequence of the S. epidermidis agr system was deter-
mined by primer walking. The ¢rst oligonucleotide that was
used for sequencing was based on the DNA sequence of the 5P
end of the coding region for the N-toxin in S. aureus and the
N-terminal amino acid sequence of the N-toxin of S. epidermi-
dis Tuº3298. The entire coding region of the agr system was
sequenced in S. epidermidis strains ATCC 14990 and Tuº3298.
The DNA sequences of the two strains were almost identical.
The hld region was sequenced in two additional S. epider-
midis strains (O-47, RP62A). The N-toxin amino acid sequence
of RP62A was the same as that of S. epidermidis ATCC 14990
and Tuº3298. The hld sequence of S. epidermidis O-47 revealed
an additional methionine codon directly upstream of the cod-
ing region, which was the consequence of a transition point
mutation at position 31 from A to G.
4. Discussion
4.1. Biological activity of the pheromone peptide
Our results show that the agr system is present and func-
tional in S. epidermidis. The agr system is known to play a
pivotal role in the regulation of virulence factors in S. aureus
[1^4] and we assume that it has the same role in S. epidermi-
dis.
The biological activity of a chemically synthesised octapep-
tide containing a thiolester bond between the central cysteine
thiol and the C-terminal carboxyl group was demonstrated,
which strongly suggests that this compound is the naturally
occurring pheromone of the S. epidermidis agr system (Fig. 5).
This also implies that the pheromones of the highly similar
systems of S. lugdunensis and S. aureus, where the agr pher-
omone was ¢rst described [11], most likely harbour the same
kind of posttranslational modi¢cation.
In our assay, a detectable activity of the pheromone could
be found at a minimal concentration of 10 nM. At concen-
trations higher than 100 nM, the e¡ect could be further in-
creased only slightly. We therefore assume that the phero-
mone peptide concentration threshold which leads to the
activation of the agr system is within this concentration range.
Because the synthetic hepta- and nonapeptides containing
thiolester bonds that were derived from the agrD DNA se-
quence did not reveal signi¢cant biological activity, the struc-
ture at the N-terminus of the pheromone seems to be very
important for activity. This also means that the enzyme(s)
excising the pheromone from the AgrD precursor must
work with high precision.
After addition of the pheromone in the exponential growth
phase, an increased reporter enzyme activity was still detect-
able in stationary growth phase when compared to controls
suggesting that the pheromone is stable at least for several
hours in the extracellular medium.
Posttranslationally modi¢ed peptides are often found as
mediators of bacterial cell-cell communication in Gram-pos-
itive bacteria [13,25]. The nature of many of these modi¢ca-
tions is still unknown. The thiolactone structure has not pre-
viously been found in signalling molecules of bacteria. There
is some structural similarity to other quorum sensing systems,
which use non-peptide pheromones with oxygen- (instead of
sulphur-) containing lactone structures. The quorum sensing
signal molecules of many Gram-negative bacteria are N-acyl-
homoserine lactones [26]. In the Gram-positive bacterium
Streptomyces griseus, the control of antibiotic synthesis is
mediated by a Q-butyrolactone [27]. Thus, the lactone motif
appears to be widespread in cell-cell communication systems,
and staphylococci, by posttranslational modi¢cation of pep-
tides, seem to have developed a di¡erent approach for its
synthesis. An interesting question is what makes this chemical
structure so suitable for signalling purposes.
4.2. Sequence analysis of the S. epidermidis agr system
DNA sequence data from S. epidermidis ATCC 14990
showed that the entire agr system of S. epidermidis is very
similar to the system of S. aureus. The response regulator
AgrA shows the highest identity to that of S. aureus
(87.3%). The histidine kinase AgrC (overall identity to S. au-
reus AgrC 50.5%) has a pronounced similarity to S. aureus in
the C-terminal part of the protein, whereas the N-terminal
part shows only low similarity. Comparison of the S. aureus
and S. lugdunensis AgrC sequences had already led to spec-
ulation that the N-terminal portion might represent the region
that binds the structurally divergent pheromone peptides,
whereas the C-terminal region interacts with the highly con-
served response regulator AgrA [12], a hypothesis which is
supported by our sequence data.
The AgrD sequence reveals a pronounced similarity in the
region directly C-terminal to the pheromone peptide (Fig. 3).
This region might represent a structural element important for
the modifying reaction presumably carried out by AgrB. With
the exception of the central cysteine residue, the sequence of
the S. epidermidis peptide pheromone is not related to any
known S. aureus subgroup, nor to S. lugdunensis. In the agr
type of pheromones, only the central cysteine and its distance
to the C-terminus is conserved. These conserved structural
features are probably important for thiolactone formation.
Sequence data obtained from 15 S. epidermidis strains showed
that S. epidermidis does not reveal a heterogeneity of the
peptide pheromones as has been found in S. aureus [12], at
least among the strains investigated in this study.
The protein believed to be involved in the maturation of the
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Fig. 5. Structure of the agr peptide pheromone of Staphylococcus
epidermidis. The structure of the pheromone molecule was deter-
mined in this study by demonstration of the biological activity of a
chemically synthesised compound. It consists of the peptide
DSVCASYF containing a thiolester linkage between the central cys-
teine and the C-terminal carboxyl group. Only the central cysteine,
but not the rest of the amino acid sequence, is conserved in the agr
type of pheromones [12].
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peptide pheromone, AgrB, shows a relatively high identity to
those of S. aureus (51.3%) and S. lugdunensis (53.7%). The
peptide sequence of the S. epidermidis N-toxin has already
been known for some time [28]. As in S. aureus, it appears
to be encoded within the RNAIII region. In contrast, the
RNAIII region of S. lugdunensis encodes no N-toxin-like pep-
tides [29].
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